BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33692135)

  • 21. Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view.
    Tajbakhsh A; Farahani N; Gheibihayat SM; Mirkhabbaz AM; Savardashtaki A; Hamblin MR; Mirzaei H
    Int Immunopharmacol; 2021 Jan; 90():107177. PubMed ID: 33249046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to experimental autoimmune encephalomyelitis induced by neonatal tolerization to myelin basic protein: clonal elimination vs. regulation of autoaggressive lymphocytes.
    Qin YF; Sun DM; Goto M; Meyermann R; Wekerle H
    Eur J Immunol; 1989 Feb; 19(2):373-80. PubMed ID: 2467819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis.
    Turley DM; Miller SD
    J Immunol; 2007 Feb; 178(4):2212-20. PubMed ID: 17277126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
    Safavi F; Li H; Gonnella P; Mari ER; Rasouli J; Zhang GX; Rostami A
    Immunol Res; 2015 Mar; 61(3):294-302. PubMed ID: 25588867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity, tolerance and autoimmunity in the liver: A comprehensive review.
    Doherty DG
    J Autoimmun; 2016 Jan; 66():60-75. PubMed ID: 26358406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.
    Perruche S; Zhang P; Liu Y; Saas P; Bluestone JA; Chen W
    Nat Med; 2008 May; 14(5):528-35. PubMed ID: 18438416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes.
    Pujol-Autonell I; Serracant-Prat A; Cano-Sarabia M; Ampudia RM; Rodriguez-Fernandez S; Sanchez A; Izquierdo C; Stratmann T; Puig-Domingo M; Maspoch D; Verdaguer J; Vives-Pi M
    PLoS One; 2015; 10(6):e0127057. PubMed ID: 26039878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
    Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo-induced self-antigen-specific Foxp3+ regulatory T cells impair the accumulation of inflammatory dendritic cells in draining lymph nodes.
    Alissafi T; Hatzioannou A; Ioannou M; Sparwasser T; Grün JR; Grützkau A; Verginis P
    J Immunol; 2015 Jun; 194(12):5812-24. PubMed ID: 25948818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of TGF-β in Self-Peptide Regulation of Autoimmunity.
    Singh B; Krawetz MD; De Lima RM; Mukherjee R; Chaturvedi P; Lee-Chan E; Leiter EH; Summers KL
    Arch Immunol Ther Exp (Warsz); 2018 Feb; 66(1):11-19. PubMed ID: 28733878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
    Tan LJ; Vanderlugt CL; McRae BL; Miller SD
    Autoimmunity; 1998; 27(1):13-28. PubMed ID: 9482204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
    J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
    Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V
    J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice.
    Reynolds P; Gordon TP; Purcell AW; Jackson DC; McCluskey J
    J Exp Med; 1996 Nov; 184(5):1857-70. PubMed ID: 8920873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
    Szczepanik M; Tutaj M; Bryniarski K; Dittel BN
    J Neuroimmunol; 2005 Jul; 164(1-2):105-14. PubMed ID: 15899524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseases.
    Serra P; Santamaria P
    Eur J Immunol; 2018 May; 48(5):751-756. PubMed ID: 29427438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential modulation of CNS-specific effector and regulatory T cells during tolerance induction by recombinant invariant chains in vivo.
    Lange C; Doster H; Steinbach K; Kalbacher H; Scholl M; Melms A; Bischof F
    Brain Behav Immun; 2009 Aug; 23(6):861-7. PubMed ID: 19362139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.